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Abstract
Skilled management of sick premature babies and very young children has resulted in numerous
exposures of their brains to a variety of anesthetic agents designed to achieve the substantial depth of
neuronal inhibition required for complete loss of consciousness and insensitivity to pain.
Unfortunately, our recent animal findings suggest that commonly used general anesthetics are
damaging to developing neurons and cause significant neuronal deletion in vulnerable brain regions. In
addition, emerging animal and human data suggest an association between early exposure to general
anesthesia and long-term impairment of cognitive development. Consequently, the prudence of
frequent anesthesia exposure of this population is now being scrutinized. It is important to note that
on the basis of currently available information, there are still considerable differences of opinion
regarding the clinical relevance of the animal findings. Since there is insufficient evidence establishing a
clear association between animal and human findings, it would be premature to suggest major changes
in current clinical practice.
Introduction and context
The exposure of very young children to general anesthe-
sia is becoming a common occurrence. The frequency of
operating suite visits has increased, as have the lengths of
stay in intensive care units, resulting in the annual
administration of more than 3 million general anes-
thetics to the pediatric patient population [1].
These practices generally have been considered to be safe
since there were no reports indicating otherwise. Now our
work and that of others have shown that clinically used
general anesthetics are potentially damaging to the
developing mammalian brain. When used at the peak of
brain growth, which coincides with synaptogenesis, they
cause widespread neurodegeneration in vulnerable brain
regions in mammalian species [2-7]. It appears that
anesthesia-induced neuronal damage is apoptotic and
involvesseveral pathways ofcaspaseactivation, ultimately
resulting in massive DNA fragmentation [2,7-9]. Both the
intrinsic, or mitochondria-dependent apoptotic pathway
and the extrinsic, death receptor-dependent pathway get
activated by general anesthesia [7,8]. In addition, general
anesthesia was shown to cause disturbances in the
homeostasis of the neurotrophic factors (brain-derived
neurotrophicfactor,inparticular)[9].Thus,itappearsthat
general anesthesia causes highly complex disturbances in
neuronal signaling and communication at an early stage
of neuronal development and that the timing of
anesthesia exposure during brain development is crucial
in determining the severity of anesthesia-induced neuro-
toxicity; that is, the immature brain is most sensitive atthe
peak of its development [4,7].
Recent advances
Although there is no doubt that general anesthesia causes
significant patho-histological damage to the developing
animal brain, the crucial question of whether the
exposure to general anesthesia has any lasting functional
effects in humans and animals was posed. Extensive
behavioral studies of rats and mice indicate that
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genesis does indeed cause learning and memory
deficiencies, alters spontaneous behavior, and causes a
lack of habituation later in life [2,10,11]. Interestingly,
the gap in learning abilities between control and
anesthesia-treated animals progressively widens during
adulthood [2].
These preclinical studies, which clearly implicate anes-
thetic agents in a variety of behavioral disturbances
indicative of impaired neurocognitive development,
provided the major impetus for methodical investiga-
tions into the possibility of anesthesia-induced neuro-
toxicity in very young children. Although such
investigations are still at an early stage, the clinical
evidence that has emerged over the last couple of years
has begun to point to potentially detrimental effects of
anesthetic agents per se on behavioral development.
These retrospective human studies challenge the assump-
tion that the emotional shocks of hospitalization and
separation from family and the physical trauma of
surgical intervention were the main factors in children’s
regressive behavioral changes known for years to occur
postoperatively. Because the postoperative psychological
disturbances observed in children under 2 years of age
are presumed to be due, in part, to separation from
family members, it has generally (and ironically) been
thought that it is best to perform surgical procedures
immediately after infants are born, before bonding with
family members has occurred and before the infants have
become emotionally attached to the outside human
world. Unfortunately, this is the time when the brain
is perhaps most vulnerable to anesthesia-induced
neurotoxicity.
Several early studies reported that, on average, the
incidence of surgery-associated psychological distur-
bances and new behavioral disturbances in children
ranged from 9% to 20% and suggested that children
under 2 years of age were at increased risk despite the
variety of different anesthetic agents that were used
[12-15]. The first report to suggest a possible relation-
ship between anesthesia and long-term impairment of
cognitive development was by Backman and Kopf [16].
Although the surgical procedure (removal of congeni-
tal nevocytic nevi) was minor, the authors reported
an increased incidence of cognitive impairments
compared with preoperative baseline which were
described as regressive behavioral changes lasting up
to 18 months after general anesthesia. Again, children
younger than 3 years were the most sensitive. A few
of the very recent studies seem to concur with these
earlier observations. For example, a population-based,
retrospective, birth cohort study (n = 5357 children) by
Wilder et al. [17] showed that although a single
exposure to general anesthesia was not associated
with a greater risk of learning disabilities than that
among a no-exposure group, children who received
two or more general anesthesias were at significantly
increased risk for learning disabilities. Moreover, that
risk increased with longer cumulative duration of
anesthesia exposure. In support of the finding that
duration of anesthesia is potentially an important
consideration is a more recent study from this group of
investigators which shows that brief exposure to
general anesthesia at the time of cesarean birth had
no effect on cognitive development later in life [18].
Interestingly, the risks of learning deficits in children
delivered with cesarean section under general anesthe-
sia were higher compared with cesarean deliveries
under regional anesthesia.
In a large-population study, DiMaggio et al. [19] focused
on assessing learning disabilities in 93,317 patients.
Again, it was found that children who had received
anesthesia before the age of 3 years required greater use
of Medicaid services to deal with learning deficits than
did children who had not been exposed to anesthesia.
Kalkman et al. [20], in The Netherlands, looked at a
smaller population of patients who had been exposed to
anesthesia very early in life and found a higher incidence
of learning deficits during school years.
Several studies of premature infants have suggested
that behavioral disabilities later in life are more
prevalent among those who were exposed to surgery
and general anesthesia during the neonatal period than
among premature infants who were treated medically.
For example, surgically treated premature infants with
patent ductus arteriosus [21] or necrotizing enteroco-
litis [22] had worse neurological outcomes than did
premature infants who were treated medically.
Although a possible causal link between early exposure
to general anesthesia and neurocognitive deficits could
be suggested on the basis of these studies, a measure of
caution is advisable since the effects of surgery cannot
be clearly separated from the effects of anesthesia.
Also, there is the fact that congenital abnormalities
requiring surgical intervention were associated with
significant comorbidities, which could have contrib-
uted to the observed behavioral deficits. In support of
this notion is a recently published retrospective clinical
study that examines the possible causal relationship
between anesthesia administration and cognitive
impairments in monozygotic twins exposed to
anesthesia either before the age of 3 years or from
3 to 12 years of age [23]. Results have shown that
twins who were exposed to anesthesia before the age
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scores and significantly more cognitive problems than
twins not exposed to anesthesia. Interestingly, though,
the exposed twin did not differ from the non-exposed
twin, suggesting that the underlying genetic vulner-
ability of the individual to learning disability is likely
correlated with the reason for the surgery for which
anesthesia was administered. The authors conclude
that early exposure to anesthesia is a marker of an
individual’s vulnerability for later learning problems,
regardless of their exposure to anesthesia.
Implications for clinical practice
Although, to date, some clinical studies suggest that the
exposure of young children to surgery and general
anesthetics may cause significant neurocognitive deficits
and a variety of behavioral sequelae, those studies were
done retrospectively [12-25] and therefore could not
control for the many variables that come into play during
the perioperative period. However, the complex issues
associated with the design of randomized double-
blinded prospective clinical studies of very young
patients cannot be underestimated. These issues include,
but are not limited to, ethical considerations; the lack of
biomarkers of apoptosis that can safely be used in a
living organism; the complexity and meaningfulness of
various clinical outcomes, especially neurocognitive
ones; and the lack of appropriate controls.
Although it is too early to tell what implications these
findings may have on pediatric anesthesia practice, it is
of paramount importance to relentlessly pursue a better
grasp of poor neurocognitive outcomes that could be
anesthesia-induced. Even though the majority of clini-
cally used general anesthetics have been shown to induce
developmental neurodegeneration, it appears that the
timing and duration of anesthesia exposure play
important roles, thus suggesting that age, rather than
the choice of anesthesia, may be the main risk factor in
anesthesia-induced developmental sequalae.
Since the use of anesthetics in obstetric and pediatric
anesthesia is a necessity that cannot be avoided when
pregnant mothers and newborn infants present with life-
threatening conditions requiring surgery or a prolonged
sedation in the intensive care unit (or both), it is
imperative that we improve our understanding of the
mechanisms that underlie the neurotoxicity of anesthetic
agents. Though still in a very early stage, we are well on
the way to developing ways of preventing anesthesia-
induced developmental neurotoxicity so that existing
anesthetics can be used to their full advantage for
therapeutic benefits without the risk of neurotoxic side
effects.
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